Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

267 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Inhibition of JAK1/2 can overcome EGFR-TKI resistance in human NSCLC.
Kim DM, Kim MJ, Moon JH, Lee EY, Hong JK, Lee S, Koh DI, Ryu YS, Kim SM, Jung SA, Shin JS, Kim J, Park YS, Hong SW, Lee SH, Jung J, Park SS, Kim DY, Kim EH, Jeong HR, Gong JH, Kim J, Chan Kim S, Yu HN, Ki SY, Kim TW, Jin DH. Kim DM, et al. Among authors: jung sa, jung j. Biochem Biophys Res Commun. 2020 Jun 18;527(1):305-310. doi: 10.1016/j.bbrc.2020.04.095. Epub 2020 May 11. Biochem Biophys Res Commun. 2020. PMID: 32446385
Chemosensitivity to HM90822, a novel synthetic IAP antagonist, is determined by p-AKT-inducible XIAP phosphorylation in human pancreatic cancer cells.
Hong SW, Shin JS, Moon JH, Jung SA, Koh DI, Ryu Y, Park YS, Kim DY, Park SS, Hong JK, Kim EH, Kim MJ, Jeong HR, Bae IH, Ahn YG, Suh KH, Cho IJ, Kang JS, Hong YS, Lee JS, Jin DH, Kim TW. Hong SW, et al. Among authors: jung sa. Invest New Drugs. 2020 Dec;38(6):1696-1706. doi: 10.1007/s10637-020-00956-9. Epub 2020 May 27. Invest New Drugs. 2020. PMID: 32462369
Targeting β-catenin overcomes MEK inhibition resistance in colon cancer with KRAS and PIK3CA mutations.
Moon JH, Hong SW, Kim JE, Shin JS, Kim JS, Jung SA, Ha SH, Lee S, Kim J, Lee DH, Park YS, Kim DM, Park SS, Hong JK, Kim DY, Kim EH, Jung J, Kim MJ, Kim SM, Deming DA, Kim K, Kim TW, Jin DH. Moon JH, et al. Among authors: jung sa, jung j. Br J Cancer. 2019 Apr;120(9):941-951. doi: 10.1038/s41416-019-0434-5. Epub 2019 Apr 4. Br J Cancer. 2019. PMID: 30944457 Free PMC article.
SH003 selectively induces p73‑dependent apoptosis in triple‑negative breast cancer cells.
Choi EK, Kim SM, Hong SW, Moon JH, Shin JS, Kim JH, Hwang IY, Jung SA, Lee DH, Lee EY, Lee S, Kim H, Kim D, Kim YS, Choi YK, Kim HI, Choi HS, Cho SG, Kim JE, Kim KP, Hong YS, Lee WK, Lee JS, Kim TW, Ko SG, Jin DH. Choi EK, et al. Among authors: jung sa. Mol Med Rep. 2016 Oct;14(4):3955-60. doi: 10.3892/mmr.2016.5722. Epub 2016 Sep 6. Mol Med Rep. 2016. PMID: 27599791
CJ14939, a Novel JAK Inhibitor, Increases Oxaliplatin-induced Cell Death Through JAK/STAT Pathway in Colorectal Cancer.
Hong JK, Kim DY, Shin JS, Ryu YS, Moon JH, Koh DI, Lee S, Lee J, Lee WJ, Lee EY, Jung SA, Kim SC, Yu HN, Kim MJ, Hong SW, Park SS, Jung J, Kim SM, Kim EH, Jeong HR, Gong JH, Kim J, Kim TW, Jin DH. Hong JK, et al. Among authors: jung sa, jung j. Anticancer Res. 2022 Apr;42(4):1813-1819. doi: 10.21873/anticanres.15657. Anticancer Res. 2022. PMID: 35346999
267 results